These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37958399)

  • 21. Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy.
    Adamus G; Karren L
    J Autoimmun; 2009 Mar; 32(2):133-9. PubMed ID: 19269136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV.
    Kim CY; Whittington DA; Chang JS; Liao J; May JA; Christianson DW
    J Med Chem; 2002 Feb; 45(4):888-93. PubMed ID: 11831900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase II increases the activity of the human electrogenic Na+/HCO3- cotransporter.
    Becker HM; Deitmer JW
    J Biol Chem; 2007 May; 282(18):13508-21. PubMed ID: 17353189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides.
    Innocenti A; Villar R; Martinez-Merino V; Gil MJ; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4872-6. PubMed ID: 16165351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia.
    Li Z; Jiang L; Chew SH; Hirayama T; Sekido Y; Toyokuni S
    Redox Biol; 2019 Sep; 26():101297. PubMed ID: 31442913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit.
    Ghislat G; Rahman T; Ballester PJ
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33227945
    [No Abstract]   [Full Text] [Related]  

  • 27. Carbonic anhydrase: in the driver's seat for bicarbonate transport.
    Sterling D; Reithmeier RA; Casey JR
    JOP; 2001 Jul; 2(4 Suppl):165-70. PubMed ID: 11875254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New aromatic/heteroaromatic propanesulfonylhydrazone compounds: synthesis, physical properties and inhibition studies against carbonic anhydrase II (CAII) enzyme.
    Özmen Özdemir Ü; Altuntaş A; Gündüzalp AB; Arslan F; Hamurcu F
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jul; 128():452-60. PubMed ID: 24682061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte C1-/HCO3- exchanger.
    Vince JW; Reithmeier RA
    J Biol Chem; 1998 Oct; 273(43):28430-7. PubMed ID: 9774471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the energetics of dissociation of carbonic anhydrase-ligand complexes in the gas phase.
    Gao J; Wu Q; Carbeck J; Lei QP; Smith RD; Whitesides GM
    Biophys J; 1999 Jun; 76(6):3253-60. PubMed ID: 10354450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.
    Indovina P; Casini N; Forte IM; Garofano T; Cesari D; Iannuzzi CA; Del Porro L; Pentimalli F; Napoliello L; Boffo S; Schenone S; Botta M; Giordano A
    J Cell Physiol; 2017 Jan; 232(1):129-35. PubMed ID: 27037775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The functional and physical relationship between the DRA bicarbonate transporter and carbonic anhydrase II.
    Sterling D; Brown NJ; Supuran CT; Casey JR
    Am J Physiol Cell Physiol; 2002 Nov; 283(5):C1522-9. PubMed ID: 12372813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma.
    Wang S; Hwang EE; Guha R; O'Neill AF; Melong N; Veinotte CJ; Conway Saur A; Wuerthele K; Shen M; McKnight C; Alexe G; Lemieux ME; Wang A; Hughes E; Xu X; Boxer MB; Hall MD; Kung A; Berman JN; Davis MI; Stegmaier K; Crompton BD
    Clin Cancer Res; 2019 Jul; 25(14):4552-4566. PubMed ID: 30979745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.
    Genis C; Sippel KH; Case N; Cao W; Avvaru BS; Tartaglia LJ; Govindasamy L; Tu C; Agbandje-McKenna M; Silverman DN; Rosser CJ; McKenna R
    Biochemistry; 2009 Feb; 48(6):1322-31. PubMed ID: 19170619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol alters carbonic anhydrase-mediated renal sulfate secretion.
    Pelis RM; Goldmeyer JE; Crivello J; Renfro JL
    Am J Physiol Regul Integr Comp Physiol; 2003 Dec; 285(6):R1430-8. PubMed ID: 12907415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonenzymatic proton handling by carbonic anhydrase II during H+-lactate cotransport via monocarboxylate transporter 1.
    Becker HM; Deitmer JW
    J Biol Chem; 2008 Aug; 283(31):21655-67. PubMed ID: 18539591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
    Qasim SL; Sierra L; Shuck R; Kurenbekova L; Patel TD; Rajapakshe K; Wulff J; Nakahata K; Kim HR; Landesman Y; Unger TJ; Coarfa C; Yustein JT
    Oncogene; 2021 Feb; 40(6):1176-1190. PubMed ID: 33414491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates.
    Roundhill EA; Pantziarka P; Liddle DE; Shaw LA; Albadrani G; Burchill SA
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer.
    Sheng W; Dong M; Zhou J; Li X; Dong Q
    J Surg Oncol; 2013 Apr; 107(5):536-43. PubMed ID: 23090763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma.
    Zhou Y; Fang Y; Zhou J; Liu Y; Wu S; Xu B
    Front Genet; 2021; 12():771253. PubMed ID: 34899858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.